碳水化合物抗原125在充血性心力衰竭中:准备好临床应用吗?
Rui Feng1,2, Zhenlu Zhang1, Qingkun Fan1
1Department of Laboratory Medicine, Wuhan Asian Heart Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Frontiers in oncology
|November 29, 2023
概括
碳水化合物抗原125 (CA125) 是一种有前途的生物标志物,用于监测急性心力衰竭 (AHF) 中的组织拥堵. 这可能会导致对充血性心力衰竭 (HF) 患者更个性化的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 瘤学 (历史背景)
背景情况:
- 拥堵是急性心力衰竭 (AHF) 进展的关键驱动因素和关键治疗目标.
- 在个性化AHF治疗中,区分血管内和组织拥堵至关重要,但仍然具有挑战性.
- 碳水化合物抗原125 (CA125) 传统上用于卵巢癌诊断.
研究的目的:
- 探索CA125作为评估急性心力衰竭 (AHF) 组织拥堵的生物标志物的潜力.
- 评估CA125在监测和指导充血性心力衰竭 (HF) 治疗中的实用性.
主要方法:
- 分析CA125对组织拥堵的敏感性.
- 将CA125与其他对HF患者右心功能的生物标志物进行比较.
主要成果:
- CA125对组织拥堵高度敏感,表明其潜在的临床价值.
- 在评估高频率患者的右心功能方面,CA125比其他生物标志物具有优势.
结论:
- CA125显示出作为充血性心力衰竭 (HF) 的新生物标志物的显著潜力.
- 在临床实践中,CA125可能成为监测拥堵和优化治疗的宝贵工具.
相关概念视频
Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
96
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
96
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Cardiac Catheterization II: Right Heart Catheterization
23
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
23
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: β-Blockers
342
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
342


